Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kena C Miller

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphomaAsher Chanan-Khan, Tariq Islam, Arif Alam, et al.
American Journal of Clinical Pathology|March 21, 2012
Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detectionMatthew T Smonskey, AnneMarie W Block, George Deeb, et al.
The Journal of Supportive Oncology|January 7, 2012
Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patientsAbhisek Swaika, Aneel Paulus, Kena C Miller, et al.
Leukemia & Lymphoma|April 7, 2010
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysisRachid Baz, Mehul Patel, Elizabeth Finley-Oliver, et al.
Cancer|April 28, 2011
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical responseAsher Chanan-Khan, Kena C Miller, David Lawrence, et al.
Blood|December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyAsher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
British Journal of Haematology|December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent mannerAisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Blood|July 30, 2005
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)Asher Chanan-Khan, Kena C Miller, Kenichi Takeshita, et al.
Cancer|October 29, 2009
Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myelomaSikander Ailawadhi, Ahmed N Abdelhalim, Lyudmyla Derby, et al.
Leukemia & Lymphoma|June 1, 2013
Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cellsKasyapa S Chitta, A Nazmul H Khan, Noreen Ersing, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphomaAsher Chanan-Khan, Tariq Islam, Arif Alam, et al.
American Journal of Clinical Pathology|March 21, 2012
Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detectionMatthew T Smonskey, AnneMarie W Block, George Deeb, et al.
The Journal of Supportive Oncology|January 7, 2012
Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patientsAbhisek Swaika, Aneel Paulus, Kena C Miller, et al.
Leukemia & Lymphoma|April 7, 2010
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysisRachid Baz, Mehul Patel, Elizabeth Finley-Oliver, et al.
Cancer|April 28, 2011
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical responseAsher Chanan-Khan, Kena C Miller, David Lawrence, et al.
Blood|December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective studyAsher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
British Journal of Haematology|December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent mannerAisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Blood|July 30, 2005
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)Asher Chanan-Khan, Kena C Miller, Kenichi Takeshita, et al.
Cancer|October 29, 2009
Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myelomaSikander Ailawadhi, Ahmed N Abdelhalim, Lyudmyla Derby, et al.
Leukemia & Lymphoma|June 1, 2013
Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cellsKasyapa S Chitta, A Nazmul H Khan, Noreen Ersing, et al.
Pageof 3